A contrast injector system includes one or more devices for reducing or eliminating risk of cross-patient contamination. In particular, the contrast injector system includes at least one of a sterilization device, vibration device, and illuminator device positioned on a component of the contrast injector system, where the sterilization device, vibration device, and/or illuminator device is in communication with a console of the contrast injector system. The sterilization device has an energy emitter positioned to emit energy to one or more components of the system. The vibration device is positioned on a component of the system so as to induce acoustic vibrations on a surface of such component. The illuminator device includes a light source positioned to illuminate a component of the system.

A triple three-way valve device comprises: a valve body (1) having a distal end and a proximal end, wherein the proximal end of the valve body (1) is connected with a control knob (2) that is radially rotatable relative to the valve body (1); and a valve rod (3) having a distal end and a proximal end, wherein the valve rod (3) is provided within the valve body (1) and is fixedly connected with the control knob (2). The distal end of the valve body (1) is connected with a seat body (4), which is connected with a plurality of liquid passages and a high pressure pipe passage; a selection member (5) provided at the distal end of the valve body (1), wherein, depending on the position of the control knob (2), the selection member (5) selects the communication relationships between the plurality of liquid passages of the seat body (4), the high pressure pipe passage and the valve rod. With the triple three-way valve device, angiocardiography surgery is simplified, and surgery safety and efficiency are improved.

An embodiment of a segmentation solution for use in diagnostic imaging applications is proposed. A corresponding embodiment of a data-processing segmentation method comprises: providing a representation over a non-zero analysis time period of a body-part being perfused with a contrast agent, the representation comprising, for each location of a set of locations of the body-part, an indication of a response over the analysis time period of the location to an interrogation signal; calculating, for each selected location of a set of selected locations, the value of at least one statistical parameter of a statistical distribution of the response over the analysis time period of the selected location, the set of selected locations comprising all the locations or a part thereof; and segmenting the selected locations according to a comparison between the values of said at least one statistical parameter for the selected locations with at least one segmentation threshold.

An injection system includes: a syringe having a cylinder to be filled with a chemical liquid, a flange projecting laterally from the cylinder, an end portion through which the chemical liquid passes when the chemical liquid is pushed out, and a syringe screw portion formed on a side opposite to the end portion; an adapter for holding the syringe, the adapter having a receiving portion for receiving the cylinder, a regulating wall for abutting the flange, and an adapter screw portion engaged with the syringe screw portion; and an injection device provided with a holder to which the adapter is to be attached. In this injection system, a tightening direction by the syringe screw portion and the adapter screw portion is set in a direction toward the end portion.

Polymeric particles are provided for use in therapeutic and/or diagnostic procedures. The particles include poly[bis(trifluoroethoxy)phosphazene and/or a derivative thereof which may be present throughout the particles or within an outer coating of the particles. The particles may also include a core having a hydrogel formed from an acrylic-based polymer. Such particles may be provided to a user in specific selected sizes to allow for selective embolization of certain sized blood vessels or localized treatment with an active component agent in specific clinical uses. Particles of the present invention may further be provided as color-coded microspheres or nanospheres to allow ready identification of the sized particles in use. Such color-coded microspheres or nanospheres may further be provided in like color-coded delivery or containment devices to enhance user identification and provide visual confirmation of the use of a specifically desired size of microspheres or nanospheres.

A manifold associated with a contrast injector system. The manifold may include a first fluid inlet, a second fluid inlet, a fluid outlet, a main passageway, and a valve. The first fluid inlet, second fluid inlet, and fluid outlet may be in fluid communication with the main passageway. The first fluid inlet, second fluid inlet, or fluid outlet can be connected to a conduit for communicating fluid, such as a fluid at high pressure. At least one of the first fluid inlet, second fluid inlet, or fluid outlet can have a surface finish that is in contact with the conduit.

An endovascular interventional method is provided that includes the steps of: inserting a catheter into a target blood vessel, wherein the catheter is coupled to a system that provides a continuous delivery of contrast and of a hyperosmotic fluid supply; injecting the contrast and determining a rate of flow that achieves angiographic filling of the target blood vessel at a first time; injecting the hyperosmotic fluid continuously at the rate of flow that achieves angiographic filling at the first time for a first period of time; injecting the contrast and determining a rate of flow that achieves angiographic filling of the target blood vessel at a second time following the first period of time; and injecting the hyperosmotic fluid continuously at the rate of flow that achieves angiographic filling at the second time for a second period of time.

A dual medical endoscope system can be constructed including a first and a second medical endoscope, where the first endoscope comprises an accessory channel with a proximal mounting port providing access thereto, and where the second endoscope comprises a handle body that is securely and removably attached to the proximal mounting port. An endoscope, which may be the second endoscope, can include an elongate, manipulable shaft with a distal-end visualization element and a handle body comprising at least one control surface for manipulating a distal region of the shaft, where the handle body includes a passage through which a length of the shaft is passable, and where the handle body includes a connection structure configured for securely and removably mounting the handle to a channel of another endoscope in a manner axially aligning the passage with the channel to provide a path of communication for the shaft.

A system and method of implanting pacing lead in a patient's heart. The system may include a catheter configured to by inserted through the coronary sinus ostium such that the distal end region of the catheter is positioned past the anterolateral vein and proximate at least one septal perforating vein. The catheter is configured to inject contrast proximate the septal perforating vein to identify an implant region for a pacing lead. Further, a controller is configured to deliver pacing therapy to the implant region.

Disclosed is a system to generate bubbles. The bubbles may be formed to include a substantially or medically pure gas. The bubbles may be formed on demand and in a selected small size.